IL6 and rheumatoid arthritis: Importantly, the most significant decrease in IL6 expression was observed in the co-injection group (E+HBP) (1.12 ± 0.02 vs. 1.80 ± 0.03, E+HBP vs. RA-PBS; p < 0.05).